These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13248569)

  • 1. Liver respiration, succinoxidase and DPN-cytochrome c reductase activity in vitamin K-deficiency and after treatment with long-acting anticoagulants.
    GREEN JP; SONDERGAARD E; DAM H
    Acta Pharmacol Toxicol (Copenh); 1955; 11(1):79-89. PubMed ID: 13248569
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin K and coumarin anticoagulants: dependence of anticoagulant effect on inhibition of vitamin K transport.
    Lowenthal J; Birnbaum H
    Science; 1969 Apr; 164(3876):181-3. PubMed ID: 5774189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative enzymes. I. Succinic dehydrogenase, DPN cytochrome c reductase, cytochrome oxidase and catalase in oral, liver, and brain cortex tissues.
    EICHEL B; SWANSON AA
    J Dent Res; 1957 Aug; 36(4):581-94. PubMed ID: 13449222
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF; Suttie JW
    Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants.
    Pearson DA
    Nutr Clin Pract; 2007 Oct; 22(5):517-44. PubMed ID: 17906277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular distribution of diphosphopyridine nucleotide-cytochrome c reductase and cytochrome c oxidase in mammalian brain.
    BRODY TM; WANG RI; BAIN JA
    J Biol Chem; 1952 Oct; 198(2):821-6. PubMed ID: 12999800
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of competitive vitamin K antagonist, 2-chloro-3-phytyl-1,4-naphthoquinone, for the study of the mechanism of action of vitamin K and coumarin anticoagulants.
    Lowenthal J; MacFarlane JA
    J Pharmacol Exp Ther; 1967 Sep; 157(3):672-80. PubMed ID: 6048023
    [No Abstract]   [Full Text] [Related]  

  • 8. Vitamin K antagonism of coumarin anticoagulation. A dehydrogenase pathway in rat liver is responsible for the antagonistic effect.
    Wallin R
    Biochem J; 1986 Jun; 236(3):685-93. PubMed ID: 3098238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Decrease of hemorrhagic accidents in anticoagulant therapy with coumarin derivatives by administration of vitamin K1].
    THEDERING F; BOWING G
    Munch Med Wochenschr; 1956 Mar; 98(10):340-4. PubMed ID: 13334377
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vitamin K: biochemistry, function, and deficiency. Review].
    Mijares ME; Nagy E; Guerrero B; Arocha-Piñango CL
    Invest Clin; 1998 Sep; 39(3):213-29. PubMed ID: 9780555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new assymetrical vitamin K antagonist: 3-(alpha-naphthyl)-4-hydroxycoumarin].
    MORAUX J; MEUNIER P; MENTZER C
    Arch Int Pharmacodyn Ther; 1953 May; 94(1):47-64. PubMed ID: 13066148
    [No Abstract]   [Full Text] [Related]  

  • 12. Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K.
    TOOHEY M
    Br Med J; 1952 Sep; 2(4786):687-90. PubMed ID: 12978288
    [No Abstract]   [Full Text] [Related]  

  • 13. [New insight in therapeutic anticoagulation by Coumarin derivatives].
    Oldenburg J; Seidel H; Pötzsch B; Watzka M
    Hamostaseologie; 2008 Feb; 28(1-2):44-50. PubMed ID: 18278162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the efficiency of vitamin K1 in small doses as antidote against anticoagulants of the dicoumarol type.
    GEILL T; LUND E; DAM H; SØNDERGAARD E
    Scand J Clin Lab Invest; 1954; 6(3):203-9. PubMed ID: 13205146
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathophysiology of vitamin K-deficiency and oral anticoagulants.
    Vermeer C; Hamulyák K
    Thromb Haemost; 1991 Jul; 66(1):153-9. PubMed ID: 1926045
    [No Abstract]   [Full Text] [Related]  

  • 16. [Activity of menadione reductase and level of cytochrome B5 and P-450 in liver with varying supplies of vitamin K and administration of pelentan to rats].
    Sokol'nikov AA; Shinkevich TE; Kodentsova VN; Vrzhesinskaia OA; Spirichev VB
    Vopr Med Khim; 1992; 38(5):15-7. PubMed ID: 1492386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antivitamins K and blood coagulation: a new synthetic anticoagulant, alpha-naphthyl-3-hydroxy-4-coumarin].
    MORAUX J
    Therapie; 1956; 11(1):104-16. PubMed ID: 13337764
    [No Abstract]   [Full Text] [Related]  

  • 18. The reduction of cytochrome c by reduced vitamin K1.
    WOSILAIT WD
    Biochem Pharmacol; 1961 Aug; 7():221-5. PubMed ID: 13786724
    [No Abstract]   [Full Text] [Related]  

  • 19. The control of excessive effect by anticoagulants.
    DUFF IF; GAMBLE JR; WILLIS PW; HODGSON PE; WILSON WS; POLHEMUS JA
    Ann Intern Med; 1955 Nov; 43(5):955-78. PubMed ID: 13268991
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of vitamin K and prothrombin synthesis: anticoagulants and the vitamin K--epoxide cycle.
    Bell RG
    Fed Proc; 1978 Oct; 37(12):2599-604. PubMed ID: 359368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.